---
document_datetime: 2023-09-21 17:24:45
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ellaone-epar-all-authorised-presentations_en.pdf
document_name: ellaone-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8163056
conversion_datetime: 2025-12-19 13:53:58.389706
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging       | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|---------------------------|-------------|
| EU/1/09/522/001  | ellaOne           | 30 mg      | Tablet                | Oral use                  | blister (PVC/PE/PVDC/alu) | 1 tablet    |
| EU/1/09/522/002  | ellaOne           | 30 mg      | Tablet                | Oral use                  | blister (PVC/PVDC/alu)    | 1 tablet    |
| EU/1/09/522/003  | ellaOne           | 30 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)    | 1 tablet    |